FDA Approved: BEPOTASTINE BESILATE — Supplemental Application (Bausch & Lomb Americas Inc.)

View source ↗

Summary

The FDA approved a supplemental application for bepotastine besilate (an antihistamine eye drop) submitted by Bausch & Lomb Americas Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Drugs mentioned

• Bepotastine besilate (Bepotastine besilate)

Snippet

SUPPL AP for BEPOTASTINE BESILATE (BEPOTASTINE BESILATE)